BioSpace News Archive

Ainos, Inc., f/k/a Amarillo Biosciences, Inc. (OTC PINK:AIMD), is pleased to announce that the Financial Industry Regulatory Authority, Inc. approved the Companys name change to Ainos, Inc. and AIMD as its new ticker symbol. Effective today, the Companys common stock will trade under the symboll AIMD

The American Association of Endodontists, which represents dental specialists known as endodontists who treat tooth pain and save patients’ natural teeth, released a new position statement on vital pulp therapy.

Confluent Medical Technologies Announces Expansion of the Confluent Costa Rica Manufacturing Location To Meet Growing Demand in Nitinol Processing & Specialized Catheters

Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, today announced the appointment of leading experts in gene therapy, cochlear development and molecular genetics to its Scientific Advisory Board (SAB).

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today the appointment of Prathyusha Duraibabu, CPA, MBA as Senior Vice President and Chief Financial Officer, effective June 1, 2021. Ms. Duraibabu will lead all financial activities and report to the Chief Executive Officer.

Webcast Will Highlight Progress Made to Advance a Healthier World for All and Health for Humanity 2025 Goals Live ESG Investor Update Webcast Scheduled for June 23, 2021 at 8:00 a.m. ET

Quidel Corporation (NASDAQ: QDEL) (“Quidel”) , a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that its Sofia® SARS Antigen FIA is the first rapid antigen test to receive authorization from Health Canada for serial testing for the detection of active coronavirus infection in both symptomatic and asymptomatic populations.

ModivCare Inc. (“ModivCare” or the “Company”) (Nasdaq: MODV), a technology-enabled healthcare services company that provides a suite of integrated supportive care solutions focused on improving patient outcomes, today announced that the Company is scheduled to present at the Jefferies Virtual Healthcare Conference on Thursday, June 3, 2021 at 3:30 p.m. Eastern Time.

Alignment Healthcare, Inc. (“Alignment Healthcare” or the “Company”) (Nasdaq: ALHC), a mission-based, tech-enabled Medicare Advantage company, today announced that John Kao, chief executive officer, and Thomas Freeman, chief financial officer, will participate in the 41st Annual William Blair Growth Stock Conference including a fireside chat on Thursday, June 3, 2021, at 1:40 p.m. ET.

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that Gregory M. Glenn , M.D., President of Research and Development, will present on NVX-CoV2373